Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Plscr1em1/Cya
Common Name:
Plscr1-KO
Product ID:
S-KO-18886
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Plscr1-KO
Strain ID
KOCMP-22038-Plscr1-B6J-VB
Gene Name
Plscr1
Product ID
S-KO-18886
Gene Alias
MmTRA1a; MmTRA1b; Nor1; Tra1; Tra1a; Tra1b; Tras1; Tras2
Background
C57BL/6JCya
NCBI ID
22038
Modification
Conventional knockout
Chromosome
9
Phenotype
MGI:893575
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Plscr1em1/Cya mice (Catalog S-KO-18886) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000093801
NCBI RefSeq
NM_011636
Target Region
Exon 3
Size of Effective Region
~0.1 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Plscr1, short for phospholipid scramblase 1, is a protein-coding gene with significant functions in multiple biological processes. It is involved in maintaining phospholipid distribution in cell membranes, and its expression can be induced by interferons (IFNs) [1,3,5,6,8]. PLSCR1 plays a crucial role in the host innate immunity against viral infections, and it has also been linked to cell apoptosis, cancer progression, and cell differentiation [1,2,4,5,6,7,9]. Genetic models, such as gene knockout mouse models, are valuable tools to study its functions.

In terms of viral infections, genome-wide CRISPR-Cas9 screens have identified PLSCR1 as a cell-autonomous restriction factor against live SARS-CoV-2 infection in human lung epithelia and hepatocytes. IFNγ-induced PLSCR1 restricts not only SARS-CoV-2 USA-WA1/2020 but also the Delta and Omicron lineages, and it acts on other highly pathogenic coronaviruses [1]. It interferes with the uptake of SARS-CoV-2 in both endocytic and TMPRSS2-dependent fusion routes, directly targeting SARS-CoV-2-containing vesicles to prevent spike-mediated fusion and viral escape [1]. Moreover, PLSCR1-knockout 36T-3 cells show significantly higher levels of human cytomegalovirus (HCMV) plaque formation and replication compared to parental cells, indicating that PLSCR1 negatively regulates HCMV replication [5]. In influenza A virus infection, Plscr1-/-mice are more susceptible to H1N1 SIV infection, suggesting its antiviral function in vivo [4].

In conclusion, PLSCR1 is a multifunctional gene playing essential roles in antiviral immunity, as demonstrated by gene-knockout models in the context of SARS-CoV-2, HCMV, and influenza A virus infections. It also has implications in other disease-related processes such as glaucoma-associated apoptosis of retinal ganglion cells, and the progression of basal-like breast cancer and acute myeloid leukemia [2,7,9]. The study of PLSCR1 using knockout models helps to understand its biological functions and provides insights into potential therapeutic strategies for related diseases.

References:
1. Xu, Dijin, Jiang, Weiqian, Wu, Lizhen, Wilen, Craig B, MacMicking, John D. 2023. PLSCR1 is a cell-autonomous defence factor against SARS-CoV-2 infection. In Nature, 619, 819-827. doi:10.1038/s41586-023-06322-y. https://pubmed.ncbi.nlm.nih.gov/37438530/
2. Luo, Jingyi, Lian, Qing, Zhu, Deliang, Lu, Lin, Zhao, Ling. 2022. PLSCR1 promotes apoptosis and clearance of retinal ganglion cells in glaucoma pathogenesis. In Genes & diseases, 10, 1564-1581. doi:10.1016/j.gendis.2022.05.036. https://pubmed.ncbi.nlm.nih.gov/37397520/
3. Li, Minghua. . Fortifying immunity: PLSCR1 picks battle against SARS-CoV-2. In Cell host & microbe, 31, 1417-1419. doi:10.1016/j.chom.2023.08.014. https://pubmed.ncbi.nlm.nih.gov/37708846/
4. Liu, Yueyue, Lin, Shuqian, Xie, Yunhui, Xu, Zhigang, Wu, Jiaqiang. 2022. ILDR1 promotes influenza A virus replication through binding to PLSCR1. In Scientific reports, 12, 8515. doi:10.1038/s41598-022-12598-3. https://pubmed.ncbi.nlm.nih.gov/35595813/
5. Sadanari, Hidetaka, Takemoto, Masaya, Ishida, Tomoki, Murayama, Tsugiya, Kusano, Shuichi. 2022. The Interferon-Inducible Human PLSCR1 Protein Is a Restriction Factor of Human Cytomegalovirus. In Microbiology spectrum, 10, e0134221. doi:10.1128/spectrum.01342-21. https://pubmed.ncbi.nlm.nih.gov/35138119/
6. Ma, Ruiyi, Zhang, Xinyi, Li, Ruonan, Lei, Xiaobo, Wang, Jianwei. 2025. PLSCR1 suppresses SARS-CoV-2 infection by downregulating cell surface ACE2. In Journal of virology, 99, e0208524. doi:10.1128/jvi.02085-24. https://pubmed.ncbi.nlm.nih.gov/39945535/
7. Huang, Panpan, Liao, Ruocen, Chen, Xingyu, Cao, Qianhua, Dong, Chenfang. 2020. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer. In Theranostics, 10, 4644-4658. doi:10.7150/thno.43150. https://pubmed.ncbi.nlm.nih.gov/32292520/
8. Le Pen, Jérémie, Paniccia, Gabrielle, Kinast, Volker, MacDonald, Margaret R, Rice, Charles M. 2024. A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist. In PLoS biology, 22, e3002767. doi:10.1371/journal.pbio.3002767. https://pubmed.ncbi.nlm.nih.gov/39316623/
9. Li, Hui, Xu, Jingyan, Zhou, Yuxin, Guo, Qinglong, Hui, Hui. 2017. PLSCR1/IP3R1/Ca2+ axis contributes to differentiation of primary AML cells induced by wogonoside. In Cell death & disease, 8, e2768. doi:10.1038/cddis.2017.175. https://pubmed.ncbi.nlm.nih.gov/28492556/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest